MicroRNA‐383 inhibits doxorubicin resistance in hepatocellular carcinoma by targeting eukaryotic translation initiation factor 5A2

Drug resistance occurs commonly in cancers, especially in hepatocellular carcinoma (HCC). Accumulating evidence has demonstrated that microRNAs (miRNAs) play a vital role in tumour chemoresistance. However, little is known about the role of miR‐383 in HCC chemoresistance. In the present study, RT‐PC...

Descripción completa

Detalles Bibliográficos
Autores principales: Tu, Chaoyong, Chen, Wei, Wang, Shuqian, Tan, Wei, Guo, Jingqiang, Shao, Chuxiao, Wang, Weilin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6815770/
https://www.ncbi.nlm.nih.gov/pubmed/30801960
http://dx.doi.org/10.1111/jcmm.14197

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6815770/
https://www.ncbi.nlm.nih.gov/pubmed/30801960
http://dx.doi.org/10.1111/jcmm.14197

Ejemplares similares